Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.51 USD | +0.42% | -1.63% | -35.91% |
May. 06 | Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating | MT |
May. 01 | (CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20 | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.31 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Employment Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.91% | 505M | B+ | ||
-15.25% | 9.26B | A- | ||
-28.46% | 6.49B | A- | ||
-18.39% | 6.28B | B+ | ||
-9.40% | 3.43B | A- | ||
-7.35% | 3.26B | C+ | ||
+2.93% | 1.51B | - | ||
+9.84% | 1.49B | - | ||
-11.25% | 1.34B | - | ||
-8.41% | 1.16B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CCRN Stock
- Ratings Cross Country Healthcare, Inc.